Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Interest Coverage Ratio of 19.78 for Q1 2026, up 42.53% sequentially from 34.42 in Q4 2025, and up 33.36% YoY from 14.84 in Q1 2025.
Acumen Pharmaceuticals (ABOS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Interest Coverage Ratio for 7 years, with the latest figure at 19.78 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 33.36% year-over-year to 19.78 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29.27 (down 12.69% YoY) and the FY2025 annual result came in at 1.45, up 28.33% from the prior year.
- Interest Coverage Ratio grew to 19.78 in Q1 2026 per ABOS's latest filing, from 34.42 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 124.98 in Q4 2022 and troughed at 336.95 in Q2 2023.
- A 5-year average of 71.06 and a median of 27.26 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 99.83% in 2022, then sank 40356.01% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 124.98 in 2022, then sank by 187.52% to 109.38 in 2023, then jumped by 80.11% to 21.76 in 2024, then tumbled by 58.23% to 34.42 in 2025, then jumped by 42.53% to 19.78 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 19.78, 34.42, and 24.82 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Acumen Pharmaceuticals | 229.03 Mn | 229.03 Mn | - | -29.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.76 |
| Mar 31, 2026 | -19.78 |
| Dec 31, 2025 | -34.42 |
| Sep 30, 2025 | -24.82 |
| Jun 30, 2025 | -39.91 |
| Mar 31, 2025 | -29.69 |
| Dec 31, 2024 | -21.76 |
| Sep 30, 2024 | -31.42 |
| Jun 30, 2024 | -24.28 |
| Mar 31, 2024 | -17.77 |
| Dec 31, 2023 | -109.38 |
| Jun 30, 2023 | -336.95 |
| Mar 31, 2023 | -328.38 |
| Dec 31, 2022 | 124.98 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | -0.83 |
| Mar 31, 2022 | -242.26 |
| Dec 31, 2021 | 365.87 |
| Sep 30, 2021 | -171.09 |
| Jun 30, 2021 | -0.07 |